Literature DB >> 24262197

Re-thinking the biology of essential tremor: from models to morphology.

Elan D Louis1.   

Abstract

Remarkably little has been written on the biology of essential tremor (ET), despite its high prevalence. The traditional pathophysiological model for ET, the olivary model, states that ET is a primary electrical//electrophysiological entity, the result of pacemaking neurons in the inferior olivary nucleus that begin firing in a coupled and rhythmic manner, and thus, through an abnormal olivo-cerebellar output, produce tremor. Though this model is based on several sound neurophysiological observations, there are major problems as well. Despite its shortcomings, however, the model persists. With the traditional focus in ET on clinical neurophysiology, there has been little research on pathological anatomy, cell biology, and molecular mechanisms, and over the years, there have been few alternatives to the olivary model. However, rigorous tissue-based studies have recently identified a series of structural changes in the ET brain, most of which are centered on the Purkinje cell and connected neuronal populations, and which may involve a partial loss of Purkinje cells. An implication of these newer studies is that ET could be degenerative. This shift in paradigm opens the door for research that aims to identify the primary set of molecular triggers and the cascade of molecular/cellular events that accompany this disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biology; Essential tremor; Neurodegeneration; Olivary model; Pathophysiology

Mesh:

Substances:

Year:  2014        PMID: 24262197     DOI: 10.1016/S1353-8020(13)70023-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  39 in total

1.  Reduced body mass index in essential tremor: a study of 382 cases and 392 matched controls.

Authors:  E D Louis; M Michalec
Journal:  Eur J Neurol       Date:  2014-11-04       Impact factor: 6.089

2.  Anti-Tremor Action of Subtype Selective Positive Allosteric Modulators of GABAA Receptors in a Rat Model of Essential Tremors.

Authors:  Dipak V Amrutkar; Tino Dyhring; Thomas A Jacobsen; Janus S Larsen; Karin Sandager-Nielsen
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

Review 3.  Essential Tremor: A Common Disorder of Purkinje Neurons?

Authors:  Elan D Louis
Journal:  Neuroscientist       Date:  2015-06-04       Impact factor: 7.519

4.  Reduced Purkinje cell dendritic arborization and loss of dendritic spines in essential tremor.

Authors:  Elan D Louis; Michelle Lee; Rachel Babij; Karen Ma; Etty Cortés; Jean-Paul G Vonsattel; Phyllis L Faust
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

Review 5.  Essential tremor then and now: How views of the most common tremor diathesis have changed over time.

Authors:  Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2017-07-13       Impact factor: 4.891

Review 6.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

Review 7.  Essential tremor: from bedside to bench and back to bedside.

Authors:  Elan D Louis
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

8.  Matching asymmetry of tremor with asymmetry of postmortem cerebellar hemispheric changes in essential tremor.

Authors:  Elan D Louis; Michelle Lee; Etty Cortés; Jean-Paul G Vonsattel; Phyllis L Faust
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

9.  Statin Use and Its Association with Essential Tremor and Parkinson's Disease.

Authors:  Sherif Y Shalaby; Elan D Louis
Journal:  Neuroepidemiology       Date:  2016-06-16       Impact factor: 3.282

Review 10.  From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor.

Authors:  Elan D Louis
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.